UCSF

Tagged: Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG)

Koda-Kimble Seed Award supports School of Pharmacy's boldest ideas

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

Research points to individualized treatments for curing TB

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

QBI pioneers a collaborative and inclusive approach to scientific discovery

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

Cancelled: Innovations in Regulatory Science Summit by UCSF-Stanford CERSI

Sat Jan 5, 2019 - 8:00 am to 5:00 pm

Due to the Federal Government shutdown, this event has been cancelled. Please join our mailing list to be notified when the event is rescheduled.

The dean advocates for medication lists and pharmacist engagement in patient care

Medical errors are the third leading cause of death in the U.S., trailing cancer and heart disease. Many of those errors can be traced back to issues with medications.

Stopping cancer in its tracks

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Sali elected to National Academy of Sciences

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

Behind enemy lines

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

Pages